News
How a decades-old sushi party, federal trial and sprawling online conspiracy community turned Sean "Diddy" Combs into the ...
A 4,000-year-old human rib bearing arrowhead found in Spain’s Pyrenees reveals signs of survival after a violent Bronze Age attack.
“Preserved blood vessel structures, like we have found in Scotty’s rib bone, appear linked to areas where the bone was ...
After the splashdown in California, Shubhanshu Shukla and his crewmates were assisted out of the capsule by SpaceX recovery ...
Modern Engineering Marvels on MSN16h
How Three Nations Broke a 40-Year Silence in Space—and What It Means for the Future of OrbitFor over a half century, the voice of Poland, Hungary, and India had been unheard in the halls of space. This July, all of that changed as astronauts from each country—Shubhanshu Shukla, Sławosz ...
Modern Engineering Marvels on MSN16h
What India’s First ISS Astronaut Saw and Changed on Axiom Mission 4How does India look from space? ” That, once-a-dozen response by Rakesh Sharma in 1984, was echoed again this week aboard the International Space Station. Group Captain Shubhanshu Shukla, India’s ...
4,000-year-old human rib discovered high in the Pyrenees still has an arrowhead from a brutal attack
A human rib discovered high in the Pyrenees suggests that someone survived a shot in the back several millennia ago.
Mereo BioPharma Group plc's ORBIT study for setrusumab in osteogenesis imperfecta moves to final analysis by 2025. Click for ...
Partners Ultragenyx and Mereo BioPharma saw their stocks drop by 21% and 30%, respectively, after announcing that the Phase ...
Analysts are keeping the faith in Ultragenyx’s brittle bone disease medicines despite the monoclonal antibody failing to score an early outright win in an ongoing phase 3 trail. | Analysts are keeping ...
Ultragenyx (RARE) stock and Mereo (MREO) stock are in selloff after a trial update on thier bone disorder therapy UX143. Read ...
Shares of Ultragenyx Pharmaceutical and Mereo BioPharma declined after the companies said a portion of a study evaluating a treatment for osteogenesis imperfecta is progressing toward a final analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results